ACONW
Aclarion, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.03
+23.83%Price chart
Aug 11Aug 14Aug 19Aug 25Aug 28Sep 2Sep 9Sep 17
Key dataSep 17, 2026
Open$0.03
From 52W high−69.25%
Volume12.00
Market cap$18461.16
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataSep 17, 2026
Open
$0.03
From 52W high
−69.25%
Volume
12.00
Market cap
$18461.16
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.8x
P/E (TTM)
—
RSI (14)
54.6
MomentumView details →
1D Return
+23.83%
YTD Return
−16.36%
SummaryUpdated Jun 1, 2026
Aclarion, Inc. (NASDAQ:ACON) is a healthcare technology company founded in 2008 and headquartered in San Mateo, California. Originally known as Nocimed, Inc., the company changed its name to Aclarion in December 2021 and went public in April 2022. The company specializes in developing software applications for magnetic resonance spectroscopy (MRS) technology, specifically targeting the diagnosis and treatment of degenerative spinal conditions. As a relatively young public company, Aclarion operates in the emerging field of medical imaging software, focusing on providing clinicians with advanced diagnostic tools to better understand and treat chronic back pain.
Similar companies
Latest newsMore news →
Aclarion announced the University of Arizona College of Medicine – Phoenix as a new clinical site in its CLARITY trial, bringing the total to ten actively enrolling sites.31d agoAclarion, Inc. announced that the United States Patent and Trademark Office issued a Notice of Allowance for its patent application titled 'Multi-Voxel Prescription for Lumbar Disc Evaluation', extending its IP protection to over 65 issued and pending patents worldwide.39d agoAclarion announced that its Nociscan platform is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, the first site in Indiana to offer the technology.47d ago